611 results on '"Wenning, G"'
Search Results
2. Progressive Supranuclear Palsy and Corticobasal Degeneration
3. Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment
4. Neural transplantation in animal models of multiple system atrophy: a review
5. Exkurs: Progressive supranukleäre Blickparese
6. Exkurs: Multisystematrophie
7. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study
8. Supplement to: Multiple-system atrophy.
9. Review: Multiple system atrophy: emerging targets for interventional therapies
10. A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type
11. Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group
12. Tilt-table testing predicts pathological nocturnal blood pressure profiles in Parkinsonʼs disease and multiple system atrophy: 1528
13. Mortality in Parkinsonʼs disease: A 38 year follow-up study: 1055
14. Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group: 335
15. PROMESA: Progression rate of MSA under EGCG supplementation as anti-aggregation-approach: 307
16. Clinical characteristics of long-term survivors in multiple system atrophy: An analysis of the EMSA-SG registry: 299
17. Extending the phenotype of transgenic MSA: Presence of h-a-syn in PNS - An update: 303
18. The potential of diameter and planimetry algorithm in the differential diagnosis of PSP: 238
19. HDAC inhibition by sodium phenylbutyrate protects catecholaminergic neurons in a transgenic mouse model of multiple system atrophy: Implications for therapy: 87
20. Age-related analysis of striatonigral degeneration and olivopontocerebellar atrophy in the PLP-α-synuclein transgenic mouse model of MSA: 86
21. Effects of late start MPO inhibition in a preclinical model of multiple system atrophy: 45
22. Multiple system atrophy - clinical variations and autonomic problems: FW9-2
23. Apomorphine responsivity in hemiparkinson hemiatrophy syndrome: a case report: EP4220
24. Orthostatic hypotension and attention in Parkinson’s disease with and without dementia
25. How to diagnose MSA early: the role of magnetic resonance imaging
26. The European Multiple System Atrophy-Study Group (EMSA-SG)
27. Management of multiple system atrophy: state of the art
28. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy)
29. Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice
30. The (alpha)-synuclein gene in multiple system atrophy
31. Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort
32. No association of GBA mutations and multiple system atrophy
33. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression
34. A novel grading scale for striatonigral degeneration (multiple system atrophy)
35. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia
36. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
37. Gleichgewichtsstörungen bei idiopathischer Parkinson-Erkrankung Der Einfluss zerebrovaskulärer Komorbidität: Der Einfluss zerebrovaskulärer Komorbidität
38. Clinical characteristics of the geste antagoniste in cervical dystonia
39. EFNS/MDS-ES recommendations for the diagnosis of Parkinsonʼs disease
40. L01 Sleep in patients with huntingtonʼs disease: an interim analysis
41. EFNS/MDS-ES recommendations for the diagnosis of Parkinsonʼs disease: FW 4-4
42. PATHOGENESIS: FW 11-2
43. TDP-43 pathology occurs infrequently in multiple system atrophy
44. Signs of early cellular dysfunction in multiple system atrophy
45. The dual nature of microglia activation in alpha-synucleinopathies: new insights from a transgenic model: SC103
46. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy
47. Decision making under risk and under ambiguity in Parkinsonʼs disease
48. Dementia in multiple system atrophy: does it exist?
49. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism
50. Atypische Parkinson-Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.